Procabazi 60mg/ml Injection
Marketer
Glenmark Pharmaceuticals Ltd
Salt Composition
Cabazitaxel (60mg/ml)
Overview Procabazi 60mg/ml Injection
Procabazi 60mg/ml injection is an antineoplastic agent indicated for advanced prostate cancer. Its mechanism involves disrupting cancerous cell proliferation, leading to their demise. Administration is exclusively under a healthcare provider's direct supervision; self-medication is strictly prohibited. Dosage and frequency are determined by your physician based on individual needs and may fluctuate throughout treatment. Adhere precisely to prescribed instructions; incorrect usage or overdose risks severe adverse reactions. Therapeutic benefits may not be immediately apparent, potentially taking weeks or months to manifest; discontinue only under medical guidance. Alcohol consumption should be avoided due to the potential for exacerbated liver injury. Frequently reported side effects include thrombocytopenia, anemia, diarrhea, back pain, and alopecia. Report any persistent or worsening side effects to your doctor; mitigating strategies may be available. Given its potency, serious adverse events are possible. Procabazi can compromise immune function and potentially affect hematological, hepatic, or renal systems; regular blood monitoring is crucial. Prior to commencing treatment, disclose any pre-existing hepatic or renal conditions, along with all concurrent medications, including anti-infectives, as drug interactions are possible. This medication is contraindicated during pregnancy and lactation; fetal harm is a risk. Pregnancy prevention measures for both partners are recommended for several months post-treatment. Pre- and ongoing treatment monitoring involves regular blood tests and physical examinations.
Uses of Procabazi 60mg/ml Injection
Malignancy of the prostate gland
Major Benefits of Procabazi 60mg/ml Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Procabazi 60mg/ml Injection:
- Vomiting
- Back pain
- Weakness
- Low blood platelets
- Hair loss
- Abdominal pain
- Loss of appetite
- Anemia (low number of red blood cells)
- Diarrhea
- Stomatitis (Inflammation of the mouth)
- Blood in urine
- Constipation
- Cough
- Taste change
- Breathing problems
- Decreased white blood cell count (neutrophils)
- Nausea
How to use Procabazi 60mg/ml Injection:
The medication will be administered by your physician or their qualified assistant; self-medication is strictly prohibited.
How Procabazi 60mg/ml Injection works:
Oncaspare injection (60mg/ml) is a chemotherapy agent that disrupts the DNA of cancerous cells, thereby inhibiting their proliferation.
SAFETY ADVICE
AlcoholUNSAFE
Combining Procabazi 60mg/ml Injection and alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
Administering Procabazi 60mg/ml Injection during pregnancy poses a confirmed risk to fetal development, and its use is contraindicated. Nevertheless, in exceptional life-threatening circumstances, a physician might deem its use justifiable if the potential benefits outweigh the inherent dangers. Physician consultation is mandatory.
Breast feedingCONSULT YOUR DOCTOR
Administering Procabazi 60mg/ml Injection while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingUNSAFE
The administration of Procabazi 60mg/ml Injection can induce drowsiness, visual disturbances, and dizziness. Driving should be avoided if such effects manifest.
KidneySAFE IF PRESCRIBED
Procabazi 60mg/ml Injection can be administered safely to individuals with kidney impairment; no dosage modification is necessary. However, patients with severe or end-stage kidney disease should be monitored closely, as data on Procabazi 60mg/ml Injection use in these populations is scarce.
LiverCAUTION
Patients with liver impairment should receive Procabazi 60mg/ml Injection cautiously, potentially requiring dose modification. A physician's consultation is advised. Procabazi 60mg/ml Injection is contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Procabazi 60mg/ml Injection :
Omit a Procabazi 60mg/ml Injection dose? Seek medical advice immediately.
Facts to Know About Procabazi 60mg/ml Injection
| Label | Value |
|---|---|
| Chemical Classification | Taxane-Based Compounds |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Action Class | Cytotoxic alkaloids |
3,018 People bought this recently